[ET Net News Agency, 18 February 2025] Nomura lowered the target price for Innovent Bio
(01801) to HKD54.6 from HKD58.09 and maintained the "buy" rating.
The research house said it lifts FY24F sales estimates on announcement of better sales,
but cuts FY25-26F on potential biosimilar VBP. (rc)
|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01801 INNOVENT BIO
Nominal 
47.250 +1.100 (+2.384%) Others
18/02/2025 15:47
{I-bank focus}Nomura lowers Innovent Bio (01801) to HKD54.6
Previous︰24/02/2025 08:45 Summary of listed companies announcements (4)
Next︰07/02/2025 08:45 Summary of listed companies announcements (3)
07/04/2025 09:21 {Hot Stocks} HK MMA stocks of price swing in pre-opening (3)
27/03/2025 10:44 {Hot Stocks}2 listed firms see price swing at 10:43am
03/03/2025 09:06 {Block Trade}Trading session block trades at 9:05am (1)
17/01/2025 08:45 Summary of listed companies announcements (4)
16/01/2025 13:03 {Hot Stocks}INNOVENT BIO quoted at HK$29.6, down 11.5%
| Remark: | Real time quote last updated: 17/04/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |